PhaseBio Pharmaceuticals Interest Expense (Operating)

Interest Expense (Operating) of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Interest Expense (Operating) growth rates and interactive chart.


Highlights and Quick Summary

  • Interest Expense (Operating) for the quarter ending March 31, 2022 was $148 Thousand (a -20.43% decrease compared to previous quarter)
  • Year-over-year quarterly Interest Expense (Operating) decreased by -41.73%
  • Annual Interest Expense (Operating) for 2021 was $947 Thousand (a -34.46% decrease from previous year)
  • Annual Interest Expense (Operating) for 2020 was $1.45 Million (a 34.29% increase from previous year)
  • Annual Interest Expense (Operating) for 2019 was $1.08 Million (a -72.58% decrease from previous year)
  • Twelve month Interest Expense (Operating) ending March 31, 2022 was $810 Thousand (a -14.47% decrease compared to previous quarter)
  • Twelve month trailing Interest Expense (Operating) decreased by -33.99% year-over-year
Trailing Interest Expense (Operating) for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$810 Thousand $947 Thousand $1.09 Million $1.23 Million
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Interest Expense (Operating) of PhaseBio Pharmaceuticals

Most recent Interest Expense (Operating)of PHAS including historical data for past 10 years.

Interactive Chart of Interest Expense (Operating) of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Interest Expense (Operating) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.15
2021 $0.19 $0.22 $0.25 $0.29 $0.95
2020 $0.33 $0.36 $0.38 $0.38 $1.45
2019 $0.37 $1.08
2018 $3.92
2017 $2.72

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology